Skip to main content

Table 2 Quality of life and WOMAC scores at baseline and after three months

From: Association of self-efficacy, risk attitudes, and time preferences with health-related quality of life and functioning after total hip or knee replacement – Results of the MobilE-TRA 2 cohort

  

THR

  

TKR

 

Measure

Baseline

Follow-up

p-value

Baseline

Follow-up

p-value

n

75

75

 

69

69

 

EQ-5D-5L utility index (median [IQR])

0.48 [0.33, 0.77]

0.88 [0.76, 0.94]

< 0.001b

0.67 [0.46, 0.85]

0.88 [0.74, 0.94]

< 0.001b

EQ-VAS (mean (SD))

56.80 (21.95)

69.44 (21.65)

< 0.001a

60.64 (19.81)

71.04 (18.82)

0.002a

WOMAC global (mean (SD))

41.93 (17.94)

74.22 (18.45)

< 0.001a

54.36 (19.90)

70.46 (19.05)

< 0.001a

WOMAC functioning (mean (SD))

42.90 (18.52)

76.02 (19.99)

< 0.001a

58.55 (20.20)

74.10 (20.16)

< 0.001a

WOMAC pain (mean (SD))

44.40 (19.85)

80.82 (18.83)

< 0.001a

53.62 (21.28)

74.24 (18.02)

< 0.001a

WOMAC stiffness (mean (SD))

38.50 (24.64)

65.83 (23.01)

< 0.001a

50.91 (27.06)

63.04 (24.86)

0.007a

  1. All WOMAC scores were rescaled to 0–100 and inverted where high values represent a better health status; WOMAC global: aggregated score of all three WOMAC subscales equally weighted
  2. THR Total hip replacement, TKR Total knee replacement, EQ-5D-5L EuroQol Five-Dimensional Five-Level Questionnaire, EQ-VAS EuroQol visual analogue scale, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, IQR Interquartile range, SD Standard deviation
  3. P-values for differences between baseline and follow-up within groups of THR and TKR were calculated using: a t-test for paired samples, b Wilcoxon signed-rank test